Jak-STAT signal transduction pathway inhibitors (NHLBI)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameJak-STAT signal transduction pathway inhibitors (NHLBI)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSTAT transcription factors inhibitorsJanus kinase inhibitors
TargetsJanus kinaseSTAT transcription factors
Therapy Area/IndicationsRejection of organ transplantationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Heart, Lung And Blood Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Heart, Lung And Blood Institute
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A